RAVEENDRAN K.C. TO STUDY THE DESIGN AND BIOPHARMACEUTICAL EVALUATION OF NANOPARTICLES CONTAINING 5-FLUOROURACIL (5-FLUORO-H,3-H-PRIMIDINE2,4-DIONE). Journal of Population Therapeutics and Clinical Pharmacology, [S. l.], v. 31, n. 3, p. 736–763, 2024. DOI: 10.53555/jptcp.v31i3.5021. Disponível em: https://mail.jptcp.com/index.php/jptcp/article/view/5021. Acesso em: 18 nov. 2024.